DMAC – diamedica therapeutics inc. (US:NASDAQ)
Stock Stats
News
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DiaMedica Therapeutics (NASDAQ:DMAC) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA [Yahoo! Finance]
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
DiaMedica Therapeutics (NASDAQ:DMAC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Form 4 DiaMedica Therapeutics For: Jan 02 Filed by: Parsons James T.
Form 4 DiaMedica Therapeutics For: Jan 02 Filed by: Giuffre Randall Michael
Form 4 DiaMedica Therapeutics For: Jan 02 Filed by: Semba Charles Pauling
Form 8-K DiaMedica Therapeutics For: Jan 05
Form 8-K DiaMedica Therapeutics For: Dec 18
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.